Heat Biologics
Pre-Approval PRO BETA ⚫
Inactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 11/24/2021
3
Total Trials
0
Phase 3
1
Phase 2
0
Recruiting
17
Score
Pipeline by Phase
Phase 3
Phase 2
1
Phase 1
3
Therapeutic Focus
Non-small Cell Lung Cancer Advanced Solid Tumor Healthy Volunteer
Clinical Trials (3)
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Started: 4/15/2015
A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors
Started: 10/18/2019
Drug Candidates
Viagenpumatucel-L Nivolumab Pembrolizumab Pemetrexed HS-110 (viagenpumatucel-L) HS-130 PTX-35
Activity Status:
Inactive
Last Trial Started: 11/24/2021
Last Trial Ended: 11/4/2022
Trials (12 months): 0
Completed Trials: 2
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.